blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3466958

EP3466958 - NEW CRYSTAL FORMS OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR, PROCESSES FOR PREPARATION AND USE THEREOF [Right-click to bookmark this link]
Former [2019/15]NEW CRYSTAL FORM OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR MEDICINE AND PREPARATION METHOD AND USE THEREOF
[2020/06]
StatusNo opposition filed within time limit
Status updated on  05.03.2021
Database last updated on 26.04.2025
FormerThe patent has been granted
Status updated on  27.03.2020
FormerGrant of patent is intended
Status updated on  09.02.2020
FormerRequest for examination was made
Status updated on  08.03.2019
FormerThe international publication has been made
Status updated on  01.12.2017
Most recent event   Tooltip15.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 17.08.2022  [2022/33]
Applicant(s)For all designated states
Crystal Pharmaceutical (Suzhou) Co., Ltd.
B4-301 Biobay
218 Xinghu Street
Suzhou Industrial Park
Suzhou, Jiangsu 215123 / CN
[2019/15]
Inventor(s)01 / CHEN, Minhua
B4-301 Biobay 218 Xinghu Street
Suzhou Industrial Park
Suzhou Jiangsu 215123 / CN
02 / ZHANG, Yanfeng
B4-301 Biobay 218 Xinghu Street
Suzhou Industrial Park
Suzhou Jiangsu 215123 / CN
03 / ZOU, Po
B4-301 Biobay 218 Xinghu Street
Suzhou Industrial Park
Suzhou Jiangsu 215123 / CN
04 / LIU, Kai
B4-301 Biobay 218 Xinghu Street
Suzhou Industrial Park
Suzhou Jiangsu 215123 / CN
05 / ZHANG, Xiaoyu
B4-301 Biobay 218 Xinghu Street
Suzhou Industrial Park
Suzhou Jiangsu 215123 / CN
 [2019/15]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2019/15]
Application number, filing date17802197.825.05.2017
[2019/15]
WO2017CN85813
Priority number, dateCN20161035523525.05.2016         Original published format: CN201610355235
[2019/15]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017202351
Date:30.11.2017
Language:ZH
[2017/48]
Type: A1 Application with search report 
No.:EP3466958
Date:10.04.2019
Language:EN
[2019/15]
Type: B1 Patent specification 
No.:EP3466958
Date:29.04.2020
Language:EN
[2020/18]
Search report(s)International search report - published on:CN30.11.2017
(Supplementary) European search report - dispatched on:EP15.05.2019
ClassificationIPC:C07H15/14, C07H1/06
[2019/24]
CPC:
C07H15/14 (EP,US); A61K31/7028 (EP,US); A61P3/10 (EP,US);
C07H1/06 (EP,US); C07B2200/13 (US)
Former IPC [2019/15]C07H15/14, C07H1/06, A61K31/7028, A61P3/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/15]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:NEUE KRISTALLINE FORMEN EINES NATRIUMGLUCOSE-COTRANSPORTERHEMMERS, HERSTELLUNGSVERFAHREN UND VERWENDUNG DAVON[2020/06]
English:NEW CRYSTAL FORMS OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR, PROCESSES FOR PREPARATION AND USE THEREOF[2020/06]
French:NOUVELLES FORMES CRISTALLINES D'UN MÉDICAMENT INHIBITEUR DES COTRANSPORTEURS DE SODIUM-GLUCOSE, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION[2020/06]
Former [2019/15]NEUE KRISTALLINE FORM EINES NATRIUMGLUCOSE-COTRANSPORTERHEMMERS UND HERSTELLUNGSVERFAHREN UND VERWENDUNG DAVON
Former [2019/15]NEW CRYSTAL FORM OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR MEDICINE AND PREPARATION METHOD AND USE THEREOF
Former [2019/15]NOUVELLE FORME CRISTALLINE D'UN MÉDICAMENT INHIBITEUR DES COTRANSPORTEURS DE SODIUM-GLUCOSE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
Entry into regional phase21.12.2018Translation filed 
21.12.2018National basic fee paid 
21.12.2018Search fee paid 
21.12.2018Designation fee(s) paid 
21.12.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
21.12.2018Examination requested  [2019/15]
30.10.2019Amendment by applicant (claims and/or description)
10.02.2020Communication of intention to grant the patent
20.03.2020Fee for grant paid
20.03.2020Fee for publishing/printing paid
20.03.2020Receipt of the translation of the claim(s)
Opposition(s)01.02.2021No opposition filed within time limit [2021/14]
Fees paidRenewal fee
21.12.2018Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.05.2017
AL29.04.2020
AT29.04.2020
CY29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
MK29.04.2020
MT29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
TR29.04.2020
IE25.05.2020
LU25.05.2020
BE31.05.2020
CH31.05.2020
LI31.05.2020
FR29.06.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
[2022/33]
Former [2022/27]HU25.05.2017
AL29.04.2020
AT29.04.2020
CY29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
MT29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
TR29.04.2020
IE25.05.2020
LU25.05.2020
BE31.05.2020
CH31.05.2020
LI31.05.2020
FR29.06.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/23]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
IE25.05.2020
LU25.05.2020
BE31.05.2020
CH31.05.2020
LI31.05.2020
FR29.06.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/20]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SK29.04.2020
SM29.04.2020
IE25.05.2020
LU25.05.2020
CH31.05.2020
LI31.05.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/15]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SK29.04.2020
SM29.04.2020
LU25.05.2020
CH31.05.2020
LI31.05.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/10]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SK29.04.2020
SM29.04.2020
CH31.05.2020
LI31.05.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/09]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SM29.04.2020
CH31.05.2020
LI31.05.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/08]AL29.04.2020
DK29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
NL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SM29.04.2020
CH31.05.2020
LI31.05.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/04]AL29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
NL29.04.2020
RS29.04.2020
SE29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/01]FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
RS29.04.2020
SE29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/51]FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
RS29.04.2020
SE29.04.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/50]FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
SE29.04.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/48]FI29.04.2020
LT29.04.2020
SE29.04.2020
NO29.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/47]LT29.04.2020
NO29.07.2020
IS29.08.2020
Former [2020/46]IS29.08.2020
Documents cited:Search[A]WO2009014970  (LEXICON PHARMACEUTICALS INC [US], et al) [A] 1-16 * abstract * * page 10, line 8 - page 11, line 2; figure 1 * * claims 42, 72 *;
 [A]WO2010009197  (LEXICON PHARMACEUTICALS INC [US], et al) [A] 1-16 * abstract * * examples 6.8-6.11 * * figures 1, 3 *;
 [A]WO2012094293  (LEXICON PHARMACEUTICALS INC [US], et al) [A] 1-16* page 19, lines 13-27 *
International search[A]US2011077212  (SEED BRIAN [US], et al) [A] 1-29* , description, page 6, right-hand column, and the whole document *;
 [A]CN102112483  (LEXICON PHARMACEUTICALS INC) [A] 1-29 * , description, page 1, and figure legends, and the whole document *;
 [A]CN102821764  (LEXICON PHARMACEUTICALS INC) [A] 1-29 * , claim 13, and the whole document *;
 [A]CN103458875  (LEXICON PHARMACEUTICALS INC) [A] 1-29 * , claims 1-3, and the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.